BiomarkersHumans37,089 participants·Cohort studyA Circulating Proteomic Signature of Allostatic Load Is Associated with Multisystem Disease and MortalityOpen the figure at full sizeFigure 1. Development, validation, and application of ProAL50.Development, validation, and application of ProAL50.Guan et al.ProteomesMachine learningInflammationAllostatic loadCancerChronic kidney diseaseHumansThe paperGuan Y, Shen J, Li L et al.Proteomes · 10 Sep 2026doi.org/10.3390/proteomes14030047PubMed 42784208
Biological age uncertainty independently predicts mortality and health decline in humansmedRxiv · 2 Oct 2026
Four health profiles linked to heart disease and diabetes risksDiabetes, Obesity & Metabolism · 6 Oct 2026